Development and validation of an EI-GC-MS method for the determination of methadone and its major metabolites (EDDP and EMDP) in human breast milk

Journal of Analytical Toxicology

Volumn 32, Issue 7, 2008, Pages 478-484

  Nikolaou, Panagiota D ^a,b   Papoutsis, Ioannis I ^a   Maravelias, Constantinos P ^a   Spiliopoulou, Chara A ^a   Pistos, Constantinos M ^a   Calokerinos, Antony C ^b   Atta Politou, Julia ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYL 5 METHYL 3,3 DIPHENYLPYRROLIDINE; 2 ETHYLIDENE 1,5 DIMETHYL 3,3 DIPHENYLPYRROLIDINE; ACETONITRILE; DRUG METABOLITE; METHADONE;

ARTICLE; BREAST MILK; CONTROLLED STUDY; GAS CHROMATOGRAPHY; HUMAN; PRECIPITATION; PUERPERIUM; ROOM TEMPERATURE; SOLID PHASE EXTRACTION;

EID: 50949092367     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/32.7.478     Document Type: Article

References (29)

1. V. Berghella, P.J. Lim, M.K. Hill, J. Cherpes, J. Chennat, and K. Kaltenbach. Maternal methadone dose and neonatal with-drawal. Am. J. Obstet. Gynecol. 189: 312-317 (2003).
2. L.M. Jansson, R.E. Choo, C. Harrow, M. Velez, J.R. Schroeder, R. Lowe, and M.A. Huestis. Concentrations of methadone in breast milk and plasma in the immediate perinatal period. J. Hum. Lact. 23: 184-190 (2007).
3. E.J. Begg, T.J. Malpas, L.P. Hackett, and K.F. llett. Distribution of R- and S-methadone into human milk during multiple, medium to high oral dosing. Br. J. Clin. Pharmacol. 52: 681-685 (2001).
4. R.E. Choo, L.M. Jansson, K. Scheidweiler, and M.A. Huestis. A validated liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometric method for the quantification of methadone, 2-ethylidene-1,5- dimethyl-3,3-diphenylpyrrolidine (EDDP), and 2-ethyl-5-methyl-3,3- diphenylpyroline (EMDP) in human breast milk. J. Anal. Toxicol. 31: 265-269 (2007).
5. R.E. Wojnar-Horton, J.H. Kristensen, P. Yapp, K.F. Ilett, L.J. Dusci, and L.P. Hackett. Methadone distribution and excretion into breast milk of clients in a methadone maintenance programme. Br. J. Clin. Pharmacol. 44(6): 543-547 (1997).
6. B. Geraghty, E.A. Graham, B. Logan, and E.L. Weiss. Methadone levels in breast milk. J. Hum. Lact. 13: 227-230 (1997).
7. J.J. McCarthy and B.L. Posey. Methadone levels in human milk. J. Hum. Lact. 16: 115-120 (2000).
8. D.E. Hutchings. Issues of risk assessment: lessons from the use and abuse of drugs during pregnancy. Neurotoxicol. Teratol. 12: 183-189 (1990).
9. L.M. Jansson, M. Velez, and C. Harrow. Methadone maintenance and lactation: a review of the literature and current management guidelines. J. Hum. Lact. 20(1): 62-71 (2004).
10. M.E. Abdel-Latif, J. Pinner, S. Clews, F. Cooke, K. Lui, and J. Oei. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics 117: 1163-1169 (2006).
11. B.L. Philipp, A. Merewood, and S. O'Brein. Methadone and breastfeeding: new horizons. Pediatrics 111: 1429-1430 (2003).
12. J.H. Galloway, M. Ashford, I.D. Marsh, M. Holden, and A.R. Forrest. A method for the confirmation and identification of drugs of misuse in urine using solid-phase extraction and gas-liquid chromatography with mass spectrometry.J. Clin. Pathol. 51: 326-329 (1998).
13. N. Chikhi-Chorfi, C. Pham-Huy, H. Galons, N. Manuel, W. Lowenstein, J.M. Warnet, and J.R. Claude. Rapid determination of methadone and its major metabolite in biological fluids by gas-liquid chromatography with thermionic detection for maintenance treatment of opiate addicts. J. Chromatogr. B 718: 278-284 (1998).
14. C. Moore, F. Guzaldo, M.J. Hussain, and D. Lewis. Determination of methadone in urine using ion trap GC-MS in positive ion chemical ionization mode. Forensic Sci. Int. 119: 155-160 (2001).
15. U. Staerk and W.R. Külpmann. High-temperature solid-phase microextraction procedure for the detection of drugs by gas chromatography-mass spectrometry. J. Chromatogr. B 745: 399-411 (2000).
16. M.E. Alburges, W. Huang, R.L. Foltz, and D.E. Moody. Determination of methadone and its N-demethylation metabolites in biological specimens by GC-PICI-MS. J. Anal. Toxicol. 20: 362-368 (1996).
17. G.A.A. Cooper and J.S. Oliver. Improved solid-phase extraction of methadone and its two major metabolites from whole blood. J. Anal. Toxicol. 22: 389-392 (1998).
18. S. Paterson, R. Cordero, and S. Burlinson. Screening and semi-quantitative analysis of post mortem blood for basic drugs using gas chromatography-ion trap mass spectrometry. J. Chromatogr. B 813: 323-330 (2004).
19. T. Gunnar, T. Eskola, and P. Lillsunde. Fast gas chromatography/mass spectrometry assay for the validated quantitative determination of methadone and its primary metabolite EDDP in whole blood. Rapid Commun. Mass Spectrom. 20: 673-679 (2006).
20. S. Paterson, R. Cordero, M. McPhillips, and S. Carman. In-terindividual dose/concentration relationship for methadone in hair. J. Anal. Toxicol. 27: 20-23 (2003).
21. D.G. Wilkins, P.R. Nagasawa, S.P. Gygi, R.L. Foltz, and D.E. Rollins. Quantitative analysis of methadone and two major metabolites in hair by positive chemical ionization ion trap mass spectrometry. J. Anal. Toxicol. 20: 355-361 (1996).
22. A.C.S. Lucas, A.M. Bermejo, M.J. Tabernero, P. Fernández, and S. Strano-Rossi. Use of solid phase microextraction (SPME) for the determination of methadone and EDDP in human hair by GC-MS. Forensic Sci. Int. 107: 225-232 (2000).
23. F. Sporkert and F. Pragst. Determination of methadone and its metabolites EDDP and EMDP in human hair by headspace solid-phase microextraction and gas chromatography-mass spectrometry. J. Chromatogr. B 746: 255-264 (2000).
24. L. Moore, J. Wicks, V. Spiehler, and R. Holgate. Gas chromatography-mass spectrometry confirmation of Cozart RapiScan saliva methadone and opiates tests. J. Anal. Toxicol. 25: 520-524 (2001).
25. T. Gunnar, K. Ariniemi, and P. Lillsunde. Validated toxicological determination of 30 drugs of abuse as optimized derivatives in oral fluid by long column fast gas chromatography-electron impact mass spectrometry. J. Mass Spectrom. 40: 739-753 (2005).
26. M.A. ElSohly, S. Feng, and T.P. Murphy. Analysis of methadone and its metabolites in meconium by enzyme immunoassay (EMIT®) and GC-MS. J. Anal. Toxicol. 25: 40-44 (2001).
27. S. Souverain, S. Rudaz, D. Ortelli, E. Varesio, and J.L. Veuthey. Use of large particles support for fast analysis of methadone and its primary metabolite in human plasma by liquid chromatography-mass spectrometry. J. Chromatogr. B 784: 117-123 (2003).
28. H.R. Liang, R.L. Foltz, M. Meng, and P. Bennett. Method development and validation for quantitative determination of methadone enantiomers in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 806: 191-198 (2004).
29. D.M. Shakleya, L.M. Jansson, and M.A. Huestis. Validation of a LC-APCI-MS-MS method for quantification of methadone, 2-ethylidene-1,5-dimethyl- 3,3-diphenylpyrrolidine (EDDP) and 2-ethyl-5-methyl-3,3-diphenylpyraline (EMDP) in infant plasma following protein precipitation. J. Chromatogr. B 856: 267-272 (2007).